Your browser doesn't support javascript.
loading
The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving Surgery.
Nakashima, Akihiro; Yamazaki, Hideya; Suzuki, Gen; Yamada, Kei; Aibe, Norihiro; Kimoto, Takuya; Masui, Koji; Nakatsukasa, Katsuhiko; Taguchi, Tetsuya; Naoi, Yasuto.
Afiliação
  • Nakashima A; Radiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Yamazaki H; Radiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Suzuki G; Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Yamada K; Radiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Aibe N; Radiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Kimoto T; Radiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Masui K; Radiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Nakatsukasa K; Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Taguchi T; Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, JPN.
  • Naoi Y; Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Cureus ; 16(5): e60228, 2024 May.
Article em En | MEDLINE | ID: mdl-38872705
ABSTRACT
Background This study was aimed at analyzing the impact of postoperative radiotherapy (PORT) after breast-conserving surgery (BCS) on Japanese patients with early-stage breast cancer and exploring the potential of PORT omission. Materials and methods Data from 794 patients with early-stage breast cancer (T1-2, N0-1), who underwent BCS with (n = 310) or without PORT (n = 484) were retrospectively analyzed. Local control (LC) rate and breast cancer-specific survival (BCSS) were compared between the groups that received and did not receive PORT in the whole cohort and low-risk cohort (i.e., the cohort with negative surgical margin, lymph node negativity, and estrogen receptor positivity, excluding young age of 49 or less), and in low-risk subgroup using propensity-score matching. Results PORT was associated with better LC but not BCSS in the total population. In the low-risk cohort, the incidence of local recurrence in patients without and with PORT was 5.3% and 4.8%, respectively, at 10 years (p = 0.591), and 7.8% and 4.8%, respectively, according to propensity-score matching (p = 0.485). Conclusion PORT improved LC in the total population, but not BCSS or overall survival (OS). In the low-risk group analysis (negative surgical margin, lymph node negativity, estrogen receptor positivity, and age 50 years or more), equivalent LC, BCSS, and OS were found including propensity-matched comparison. Therefore, this study showed that the omission of PORT could be a treatment option for low-risk Japanese patients. Further multi-center prospective studies are warranted to validate these findings and reduce the unnecessary burden of PORT for patients and institutions.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article